tirzepatide dosage
Prescription Weight Loss: Tirzepatide Beats Semaglutide?
Tirzepatide appears to outperform semaglutide in real-world weight-loss outcomes, with a cohort of over 1,000 patients demonstrating a measurable advantage in body-composition changes. Emerging evidence suggests the dual GIP/GLP-1 agonist delivers stronger satiety signals while maintaining a safety profile comparable to existing GLP-1 therapies. Medical Disclaimer: This article